Applicability and reproducibility of acute myeloid leukaemia stem cell assessment in a multi‐centre setting
Leukaemic stem cells (LSC) have been experimentally defined as the leukaemia‐propagating population and are thought to be the cellular reservoir of relapse in acute myeloid leukaemia (AML). Therefore, LSC measurements are warranted to facilitate accurate risk stratification. Previously, we published...
Main Authors: | Hanekamp, D, Snel, AN, Kelder, A, Scholten, WJ, Khan, N, Metzner, M, Irno-Consalvo, M, Sugita, M, de Jong, A, Oude Alink, S, Eidhof, H, Wilhelm, M, Feuring-Buske, M, Slomp, J, van der Velden, VHJ, Sonneveld, E, Guzman, M, Roboz, GJ, Buccisano, F, Vyas, P, Freeman, S, Bachas, C, Ossenkoppele, GJ, Schuurhuis, GJ, Cloos, J |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Wiley
2020
|
Similar Items
-
AML/Normal Progenitor Balance Instead of Total Tumor Load (MRD) Accounts for Prognostic Impact of Flowcytometric Residual Disease in AML
by: Diana Hanekamp, et al.
Published: (2021-05-01) -
New strategies in hematopoietic stem cell transplantation: G-CSF-mobilized unprocessed whole blood
by: A.M. Dräger, et al.
Published: (1998-01-01) -
Leukemic stem cell frequency: a strong biomarker for clinical outcome in acute myeloid leukemia.
by: Monique Terwijn, et al.
Published: (2014-01-01) -
MRD Tailored Therapy in AML: What We Have Learned So Far
by: Lok Lam Ngai, et al.
Published: (2021-01-01) -
P475: EMERGING LEUKEMIA ASSOCIATED IMMUNOPHENOTYPES (LAIPS) IN BONE MARROW OF ACUTE MYELOID LEUKEMIA PATIENTS AFTER INTENSIVE CHEMOTHERAPY.
by: Lok Lam Ngai, et al.
Published: (2023-08-01)